A detailed history of Quantinno Capital Management LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Quantinno Capital Management LP holds 201,981 shares of NVO stock, worth $17.6 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
201,981
Previous 184,986 9.19%
Holding current value
$17.6 Million
Previous $26.4 Million 8.92%
% of portfolio
0.32%
Previous 0.48%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $2.02 Million - $2.47 Million
16,995 Added 9.19%
201,981 $24 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $7.95 Million - $9.52 Million
64,769 Added 53.88%
184,986 $26.4 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $387,303 - $515,544
3,793 Added 3.26%
120,217 $15.4 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $437,583 - $525,668
-4,985 Reduced 4.11%
116,424 $12 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $9.17 Million - $20.1 Million
100,802 Added 489.16%
121,409 $11 Million
Q2 2023

Aug 04, 2023

BUY
$155.98 - $172.65 $342,064 - $378,621
2,193 Added 11.91%
20,607 $3.33 Million
Q1 2023

May 03, 2023

BUY
$132.34 - $159.14 $438,310 - $527,071
3,312 Added 21.93%
18,414 $2.93 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $714,978 - $943,520
6,972 Added 85.76%
15,102 $2.04 Million
Q3 2022

Nov 07, 2022

BUY
$95.28 - $116.93 $557,673 - $684,391
5,853 Added 257.05%
8,130 $810,000
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $235,077 - $277,361
2,277 New
2,277 $254,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.